Chronic Respiratory Diseases Treatment Market: Segmentation
Chronic Respiratory Diseases Treatment Market Analysis
Chronic Respiratory Diseases Treatment Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027
- Healthcare, Pharmaceuticals and Medical devices
- Ongoing
- September 2019
- REP-GB-4387
-
This Chronic Respiratory Diseases Treatment market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Chronic Respiratory Diseases Treatment market.
Chronic respiratory diseases that affects mainly the airways and other structures of the lungs. Chronic respiratory diseases includes chronic obstructive pulmonary disease, asthma, chronic sinusitis, occupational lung diseases, and pulmonary fibrosis, among others. The aforementioned diseases don’t have any cure but they can be treatable. Asthma occurs when any person exposed to specific allergens that leads to inflammation of the airways and muscles that are around airways get tighten and makes difficult for air to move in and out of the lungs. According to CDC statistics, the prevalence of asthma getting increased over the years. The prevalence of asthma increased from 7.3% in 2001 to 8.4% by 2010. In the U.S. about 20 Mn are asthma patients and 1 in every 12 people suffers from asthma. According NCD alliance, 235 Mn people suffer from asthma worldwide. Owing to this large pool of patient population various companies are actively working on novel mechanisms and innovative dosage forms to treat chronic respiratory diseases.
Chronic Respiratory Diseases Treatment Market: Drivers and Restraints
Market Growth Analysis
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Chronic Respiratory Diseases Treatment Market:
Global Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027
Global Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027
/p>
The global chronic respiratory diseases treatment market is classified on the basis of drug class, route of administration, distribution channel, and geography.
Companies are focusing on the inhalational dosage forms owing to its faster action and quick relief than the conventional dosage forms. Various companies are developing dosage forms to reduce the dosage errors and ease to use. For instance, ProAir® HFA (albuterol sulfate) inhalational aerosol marketed by Teva Pharmaceuticals Ltd., the aerosol turns to red when the dosage in the inhaler nearly empty. Furthermore, companies developed nebulizer systems that can deliver precise inhalational solution to treat COPD conditions. BROVANA® (arformoterol tartrate) Inhalation Solution marketed by Sumitomo Dainippon Pharma Co., Ltd deliver single dose inhalational solution to treat COPD conditions.
Chronic Respiratory Diseases Treatment Market: Regional Overview
Region wise, the global chronic respiratory diseases treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. North America expected to dominate the global market for chronic respiratory diseases treatment due to favorable government policies and increase in awareness about the chronic respiratory diseases are expected to drive the growth of the market over the forecast period. Large patient pool and increase in air pollutants in the Asia –Pacific excluding Japan market are expected to boost the growth of the chronic respiratory diseases treatment market growth in APEJ region over the forecast period
Some of the players in global chronic respiratory diseases treatment market include Merck & Co., Inc., Mylan N.V.,Boehringer Ingelheim Pharmaceuticals, Inc, Teva Pharmaceutical Ltd., GlaxoSmithKline plc, Sumitomo Dainippon Pharma Co., Ltd, andAstraZeneca plc,
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
Competitive Positioning Matrix
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Average Selling Price (ASP) Analysis
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Government initiatives, favorable reimbursement policies, increasing prevalence of chronic respiratory diseases, and raise in smoking population are boosting the growth of chronic respiratory diseases treatment market over the forecast period. Furthermore, higher air pollutant levels and rapid industrialization in developing countries have positive impact on the chronic respiratory diseases treatment market. According to CDC statistics, in 2014, COPD is 4th leading cause of death in the U.S. market. Approximately 142,000 individuals died from COPD in the U.S. Lack of specific tests to diagnose the COPD conditions and side effects of the drugs are restraining the growth of the market over the forecast period.
Chronic Respiratory Diseases Treatment Market: Segmentation
Based on drug class, the global chronic respiratory diseases treatment market is segmented into the following:
- Antibiotics
- Corticosteroids
- Mucolytic agents
- Bronchodilators
- Leukotriene Modifiers
- Monoclonal antibodies
- Others
Based on route of administration, the global Chronic Respiratory Diseases Treatment market is segmented into the following:
- Oral
- Parenteral
- Inhalational
Based on distribution channel, the global Chronic Respiratory Diseases Treatment market is segmented into the following:
- Retail Pharmacies
- Hospital Pharmacies
- Mail order Pharmacies
Chronic Respiratory Diseases Treatment Market: Overview
Companies are focusing on the inhalational dosage forms owing to its faster action and quick relief than the conventional dosage forms. Various companies are developing dosage forms to reduce the dosage errors and ease to use. For instance, ProAir® HFA (albuterol sulfate) inhalational aerosol marketed by Teva Pharmaceuticals Ltd., the aerosol turns to red when the dosage in the inhaler nearly empty. Furthermore, companies developed nebulizer systems that can deliver precise inhalational solution to treat COPD conditions. BROVANA® (arformoterol tartrate) Inhalation Solution marketed by Sumitomo Dainippon Pharma Co., Ltd deliver single dose inhalational solution to treat COPD conditions.
Chronic Respiratory Diseases Treatment Market: Key Players
Some of the players in global chronic respiratory diseases treatment market include Merck & Co., Inc., Mylan N.V.,Boehringer Ingelheim Pharmaceuticals, Inc, Teva Pharmaceutical Ltd., GlaxoSmithKline plc, Sumitomo Dainippon Pharma Co., Ltd, andAstraZeneca plc,
he report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
